Literature DB >> 20450958

Cyclooxygenase inhibitors suppress the expression of P2X(3) receptors in the DRG and attenuate hyperalgesia following chronic constriction injury in rats.

Ying Wang1, Xiang Zhang, Qu-Lian Guo, Wang-Yuan Zou, Chang-Sheng Huang, Jian-Qin Yan.   

Abstract

Recent evidence suggests that P2X(3) receptors express abundantly in nociceptive sensory neurons and play an important role in neuropathic pain. Upregulation of prostaglandin E2 (PGE2) after nerve injure is involved in the pathogenesis of neuropathic pain. An increase of P2X(3) receptors after chronic constriction injury (CCI) to the sciatic nerve has also been reported, the mechanisms are not known clearly. In this study, we examined the effects of systemic administration of cyclooxygenase (COX) inhibitors on analgesia and the expression of P2X(3) receptors in the dorsal root ganglia (DRG) in CCI rats. Rats received 0.9% saline, the nonselective COX inhibitor ibuprofen (40mgkg(-1)day(-1)) or the selective COX-2 inhibitor celecoxib (30mgkg(-1)day(-1)) by gavage twice daily from 3 to 14 days after surgery. Mechanical allodynia and thermal hyperalgesia induced by CCI were markedly attenuated by celecoxib from 5 to 14 days after surgery, and relieved by ibuprofen treatment from 7 to 10 days after surgery. The increase of P2X(3) receptors in the DRG in CCI rats on day 14 after surgery was also significantly inhibited; the effect of ibuprofen was stronger than that of celecoxib. These results demonstrate that up-regulated COX/PGE2 after nerve damage may play an important role in neuropathic pain. They are highly involved in the expression of P2X(3) receptors in the DRG in CCI rats. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450958     DOI: 10.1016/j.neulet.2010.04.069

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.

Authors:  Jeffrey S Wieskopf; Jayanti Mathur; Walrati Limapichat; Michael R Post; Mona Al-Qazzaz; Robert E Sorge; Loren J Martin; Dmitri V Zaykin; Shad B Smith; Kelen Freitas; Jean-Sebastien Austin; Feng Dai; Jie Zhang; Jaclyn Marcovitz; Alexander H Tuttle; Peter M Slepian; Sarah Clarke; Ryan M Drenan; Jeff Janes; Shakir Al Sharari; Samantha K Segall; Eske K Aasvang; Weike Lai; Reinhard Bittner; Christopher I Richards; Gary D Slade; Henrik Kehlet; John Walker; Uwe Maskos; Jean-Pierre Changeux; Marshall Devor; William Maixner; Luda Diatchenko; Inna Belfer; Dennis A Dougherty; Andrew I Su; Sarah C R Lummis; M Imad Damaj; Henry A Lester; Ardem Patapoutian; Jeffrey S Mogil
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

2.  Expression of P2X5 receptors in the rat, cat, mouse and guinea pig dorsal root ganglion.

Authors:  Jun-Wei Zeng; Sai-Yu Cheng; Xiao-Hong Liu; Yan-Dong Zhao; Zhi Xiao; Geoffrey Burnstock; Huai-Zhen Ruan
Journal:  Histochem Cell Biol       Date:  2012-11-18       Impact factor: 4.304

3.  Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat.

Authors:  Jelena M Janjic; Kiran Vasudeva; Muzamil Saleem; Andrea Stevens; Lu Liu; Sravan Patel; John A Pollock
Journal:  J Neuroimmunol       Date:  2018-02-25       Impact factor: 3.478

Review 4.  Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory.

Authors:  Elizabeth J Rahn; Mikael C Guzman-Karlsson; J David Sweatt
Journal:  Neurobiol Learn Mem       Date:  2013-06-22       Impact factor: 2.877

5.  Temporal distribution of p300/CBP immunoreactivity in the adult rat spinal dorsal horn following chronic constriction injury (CCI).

Authors:  Xiao-Yan Zhu; Chang-Sheng Huang; Qian Li; Qu-Lian Guo; Ying Wang; Xin He; Juan Liao
Journal:  Cell Mol Neurobiol       Date:  2012-11-06       Impact factor: 5.046

6.  In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization.

Authors:  Anthony P Ford
Journal:  Purinergic Signal       Date:  2011-11-18       Impact factor: 3.765

7.  Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice.

Authors:  Jenny L Wilkerson; Zachary A Curry; Pamela D Kinlow; Brittany L Mason; Ku-Lung Hsu; Mario van der Stelt; Benjamin F Cravatt; Aron H Lichtman
Journal:  Pain       Date:  2018-06       Impact factor: 7.926

8.  Phospholipase A2 Inhibitor-Loaded Phospholipid Micelles Abolish Neuropathic Pain.

Authors:  Sonia Kartha; Lesan Yan; Meagan E Ita; Ahmad Amirshaghaghi; Lijun Luo; Yulong Wei; Andrew Tsourkas; Beth A Winkelstein; Zhiliang Cheng
Journal:  ACS Nano       Date:  2020-06-04       Impact factor: 15.881

9.  Common mechanisms of pain and depression: are antidepressants also analgesics?

Authors:  Tereza Nekovarova; Anna Yamamotova; Karel Vales; Ales Stuchlik; Jitka Fricova; Richard Rokyta
Journal:  Front Behav Neurosci       Date:  2014-03-25       Impact factor: 3.558

10.  Intrathecal leptin inhibits expression of the P2X2/3 receptors and alleviates neuropathic pain induced by chronic constriction sciatic nerve injury.

Authors:  Xin Li; Lumei Kang; Guilin Li; Huihong Zeng; Lei Zhang; Xiang Ling; Hui Dong; Shangdong Liang; Hongping Chen
Journal:  Mol Pain       Date:  2013-12-10       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.